Side-by-side comparison of AI visibility scores, market position, and capabilities
World's most recognized Mexican beer brand distributed by Constellation Brands in US; $7B+ annual sales with beach lifestyle positioning among the fastest-growing import beer brands.
Corona (Grupo Modelo's Corona Extra) is the world's most recognized Mexican beer brand and one of the top-selling beer brands globally, known for its clear bottle, lime-wedge serving tradition, and "Find Your Beach" beach/lifestyle marketing that has established it as an aspirational leisure beer. Corona Extra is brewed and distributed by Grupo Modelo, which was acquired by AB InBev (Anheuser-Busch InBev) in 2013 for $20.1 billion. In the United States — Corona's largest market — the brand is distributed by Constellation Brands (NYSE: STZ), which holds perpetual rights to the Corona brand for US distribution.\n\nCorona's brand architecture includes Corona Extra (the flagship), Corona Light (reduced calorie), Corona Premier (lower carb/calorie premium), and Corona Hard Seltzer (launched 2020 to compete in the seltzer category). The brand's beach lifestyle association — reinforced through the iconic beachside advertising imagery and lime customization ritual — has made it a premium import despite being an accessible price point, competing in the "above premium" mainstream import segment rather than craft beer.\n\nIn 2025, Corona is Constellation Brands' primary revenue driver in the US beer segment, generating approximately $7+ billion in annual net sales. The brand continues to outperform the broader beer category as one of the fastest-growing import beer brands in the US. Constellation's 2025 strategy focuses on Corona's ongoing premiumization (Corona Premier and Cero non-alcoholic growing faster than Extra), expanding Corona Hard Seltzer, and growing the brand among Hispanic consumers who are the core demographic driving above-average beer consumption growth. Corona competes with Modelo Especial (its AB InBev sibling, distributed by Constellation), Heineken, and domestic premiums for the above-mainstream beer consumer.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.